These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2821551)

  • 1. Antiaversive properties of opioids in the conditioned taste aversion test in the rat.
    Blancquaert JP; Lefebvre RA; Willems JL
    Pharmacol Biochem Behav; 1987 Jul; 27(3):437-41. PubMed ID: 2821551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emetic and antiemetic effects of opioids in the dog.
    Blancquaert JP; Lefebvre RA; Willems JL
    Eur J Pharmacol; 1986 Sep; 128(3):143-50. PubMed ID: 3024991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y; Bardon T; Pairet M
    Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum.
    Allescher HD; Storr M; Brechmann C; Hahn A; Schusdziarra V
    Neuropeptides; 2000 Feb; 34(1):62-8. PubMed ID: 10688971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the ability of opioid peptides and opiates to affect active avoidance conditioning in rats.
    Rigter H; Dekker I; Martinez JL
    Regul Pept; 1981 Sep; 2(5):317-32. PubMed ID: 6272375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
    Pazos A; Flórez J
    Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mu-opioid receptors in the ventral pallidum decreases the negative hedonic evaluation of a conditioned aversive taste in rats.
    Inui T; Shimura T
    Behav Brain Res; 2017 Mar; 320():391-399. PubMed ID: 27825896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
    Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
    Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.
    Mucha RF; Herz A
    Psychopharmacology (Berl); 1985; 86(3):274-80. PubMed ID: 2994144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A; Metsch R
    Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the cardiac response to sympathetic nerve stimulation by opioid peptides and its potentiation by morphine and methadone.
    Ledda F; Mantelli L; Corti V; Fantozzi R
    Eur J Pharmacol; 1984 Jul; 102(3-4):443-50. PubMed ID: 6092097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.